Recent changes
Track the most recent changes to the wiki on this page.
19 June 2013
18 June 2013
- (diff | hist) . . N Example orders for Dacarbazine (DTIC) in melanoma; 23:54 . . (+1,495) . . PeterYang (Talk | contribs) (Created page with "'''Use of this site is subject to you reading and agreeing with the terms set forth in the disclaimer.''' Rem...")
- (diff | hist) . . Acute lymphocytic leukemia; 14:16 . . (+1,885) . . Jwarner (Talk | contribs) (→Relapsed/refractory: )
- (diff | hist) . . m Chronic myelogenous leukemia; 14:15 . . (-12) . . Jwarner (Talk | contribs) (→Ponatinib (Iclusig): )
- (diff | hist) . . m Teniposide (Vumon); 14:12 . . (+67) . . Jwarner (Talk | contribs) (→Patient drug information: )
- (diff | hist) . . m Thioguanine (Tabloid); 14:11 . . (+67) . . Jwarner (Talk | contribs) (→Patient drug information: )
- (diff | hist) . . m Mercaptopurine (Purinethol); 14:11 . . (+67) . . Jwarner (Talk | contribs) (→Patient drug information: )
- (diff | hist) . . m Prednisone (Sterapred); 14:10 . . (+67) . . Jwarner (Talk | contribs) (→Patient drug information: )
- (diff | hist) . . m Imatinib (Gleevec); 14:09 . . (+101) . . Jwarner (Talk | contribs) (→Patient drug information: )
- (diff | hist) . . m Methotrexate (MTX); 14:08 . . (+67) . . Jwarner (Talk | contribs) (→Patient drug information: )
- (diff | hist) . . Style guide; 14:07 . . (+353) . . Jwarner (Talk | contribs) (→Comments: )
- (diff | hist) . . m Dexamethasone (Decadron); 14:04 . . (+67) . . Jwarner (Talk | contribs) (→Patient drug information: )
- (diff | hist) . . m Vincristine (Oncovin); 14:01 . . (+67) . . Jwarner (Talk | contribs) (→Patient drug information: )
- (diff | hist) . . m Hodgkin lymphoma; 13:55 . . (0) . . Jwarner (Talk | contribs) (→Relapsed/Refractory: )
- (diff | hist) . . m Hodgkin lymphoma; 13:54 . . (-17) . . Jwarner (Talk | contribs) (→Classical Hodgkin Lymphoma: )
- (diff | hist) . . m Chronic lymphocytic leukemia (CLL) and Small lymphocytic lymphoma (SLL); 13:54 . . (0) . . Jwarner (Talk | contribs) (→Relapsed/Refractory: )
- (diff | hist) . . m Chronic lymphocytic leukemia (CLL) and Small lymphocytic lymphoma (SLL); 13:53 . . (-1) . . Jwarner (Talk | contribs) (→First line: )
- (diff | hist) . . m Waldenström macroglobulinemia; 13:53 . . (-13) . . Jwarner (Talk | contribs)
- (diff | hist) . . m Multiple myeloma; 13:52 . . (-10) . . Jwarner (Talk | contribs) (→First-line regimens (including transplant ineligible): )
- (diff | hist) . . m Light-chain (AL) amyloidosis; 13:52 . . (-8) . . Jwarner (Talk | contribs) (→Relapsed/Refractory Disease: )
- (diff | hist) . . m Light-chain (AL) amyloidosis; 13:52 . . (-9) . . Jwarner (Talk | contribs) (→First-Line Therapy (including transplant ineligible): )
- (diff | hist) . . m Aggressive Non-Hodgkin lymphoma; 13:51 . . (-3) . . Jwarner (Talk | contribs)
- (diff | hist) . . m Aggressive Non-Hodgkin lymphoma; 13:50 . . (0) . . Jwarner (Talk | contribs) (→DLBCL, Relapsed/Refractory: )
- (diff | hist) . . m Aggressive Non-Hodgkin lymphoma; 13:50 . . (-1) . . Jwarner (Talk | contribs) (→DLBCL, First Line: )
- (diff | hist) . . m Marginal zone lymphoma; 13:48 . . (+3,269) . . Jwarner (Talk | contribs)
- (diff | hist) . . m T-cell lymphoma; 13:31 . . (+154) . . Jwarner (Talk | contribs) (→Cutaneous T-cell Lymphoma (CTCL): )
- (diff | hist) . . m T-cell lymphoma; 13:30 . . (+616) . . Jwarner (Talk | contribs) (→Peripheral T-cell Lymphoma (PTCL): )
- (diff | hist) . . m Mantle cell lymphoma; 13:28 . . (-13) . . Jwarner (Talk | contribs)
- (diff | hist) . . m Follicular lymphoma; 13:26 . . (-1) . . Jwarner (Talk | contribs) (→First-line: )
- (diff | hist) . . Chronic myelogenous leukemia; 13:24 . . (+796) . . Jwarner (Talk | contribs)
- (diff | hist) . . Imatinib (Gleevec); 13:21 . . (+371) . . Jwarner (Talk | contribs)
- (diff | hist) . . m Acute myeloid leukemia; 13:02 . . (-22) . . Jwarner (Talk | contribs) (→Consolidation a.k.a. post-remission therapy: )
- (diff | hist) . . m Acute myeloid leukemia; 13:00 . . (+4) . . Jwarner (Talk | contribs) (→Salvage therapy: )
- (diff | hist) . . m Acute lymphocytic leukemia; 12:59 . . (+3) . . Jwarner (Talk | contribs) (→Relapsed disease: )
- (diff | hist) . . Breast cancer; 10:07 . . (+2,521) . . PeterYang (Talk | contribs) (added reference, formatting)
- (diff | hist) . . m Drug index; 09:42 . . (+93) . . PeterYang (Talk | contribs) (added medications)
17 June 2013
- (diff | hist) . . m Follicular lymphoma; 23:24 . . (+85) . . Jwarner (Talk | contribs) (→VR: )
- (diff | hist) . . Mantle cell lymphoma; 23:04 . . (+1,029) . . Jwarner (Talk | contribs) (→Lenalidomide (Revlimid): )
- (diff | hist) . . m Mantle cell lymphoma; 22:58 . . (+548) . . Jwarner (Talk | contribs) (→Lenalidomide (Revlimid): )
- (diff | hist) . . T-cell lymphoma; 22:51 . . (+835) . . Jwarner (Talk | contribs) (→Bendamustine (Treanda): )
- (diff | hist) . . T-cell lymphoma; 14:05 . . (+897) . . Jwarner (Talk | contribs) (→Cutaneous T-cell Lymphoma: )
- (diff | hist) . . m T-cell lymphoma; 14:04 . . (+7) . . Jwarner (Talk | contribs) (→Peripheral T-cell Lymphoma: )
- (diff | hist) . . T-cell lymphoma; 14:04 . . (+890) . . Jwarner (Talk | contribs) (→Pralatrexate (Folotyn): )
- (diff | hist) . . Prostate cancer; 03:53 . . (+5,983) . . PeterYang (Talk | contribs) (added regimens)
- (diff | hist) . . N Example orders for Docetaxel & Carboplatin in prostate cancer; 03:15 . . (+1,852) . . PeterYang (Talk | contribs) (Created page with "'''Use of this site is subject to you reading and agreeing with the terms set forth in the disclaimer.''' Rem...")
- (diff | hist) . . N Example orders for Sipuleucel-T (Provenge) in prostate cancer; 03:03 . . (+1,871) . . PeterYang (Talk | contribs) (Created page with "'''Use of this site is subject to you reading and agreeing with the terms set forth in the disclaimer.''' Rem...")
- (diff | hist) . . N Example orders for Mitoxantrone (Novantrone) in prostate cancer; 02:56 . . (+2,100) . . PeterYang (Talk | contribs) (Created page with "'''Use of this site is subject to you reading and agreeing with the terms set forth in the disclaimer.''' Rem...")
- (diff | hist) . . N Example orders for Leuprolide (Lupron) in prostate cancer; 02:49 . . (+1,128) . . PeterYang (Talk | contribs) (Created page with "'''Use of this site is subject to you reading and agreeing with the terms set forth in the disclaimer.''' Rem...")
- (diff | hist) . . m Example orders for Goserelin (Zoladex) in prostate cancer; 02:46 . . (0) . . PeterYang (Talk | contribs)
- (diff | hist) . . m Example orders for Cabazitaxel (Jevtana) in prostate cancer; 02:45 . . (0) . . PeterYang (Talk | contribs)
